Diagnostics of messenger ribonucleic acid (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) vaccination-associated myocarditis—A systematic review
- 20.07.2022
- Review articles
Erschienen in:
- Verfasst von
- Jan M. Federspiel, MD
- Frank Ramsthaler, MD
- Mattias Kettner, MD
- Gerhard Mall, MD
- Erschienen in
- Rechtsmedizin | Ausgabe 2/2023
Abstract
Background
During the recent pandemic with the severe acute respiratory syndrome-corona virus‑2 the first messenger ribonucleic acid (mRNA) vaccines were approved. To facilitate mass vaccination, confidence of the general population in these new vaccines is mandatory, which is in turn strongly dependent on the availability of reliable data on complications.
Objective
Summary of the current knowledge on mRNA vaccination-associated myocarditis as a potentially fatal side effect.
Methods
Systematic literature review.
Results
Diagnostic algorithm for the postmortem diagnosis of mRNA vaccination-associated myocarditis.
Conclusion
Autopsy series of fatalities following mRNA SARS-CoV‑2 vaccination up to 6 weeks with subsequent sophisticated and interdisciplinary work-up are necessary to complement clinical data on vaccination-associated myocarditis, especially regarding the incidence of fatal courses.
- Titel
- Diagnostics of messenger ribonucleic acid (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) vaccination-associated myocarditis—A systematic review
- Verfasst von
-
Jan M. Federspiel, MD
Frank Ramsthaler, MD
Mattias Kettner, MD
Gerhard Mall, MD
- Publikationsdatum
- 20.07.2022
- Verlag
- Springer Medizin
- Erschienen in
-
Rechtsmedizin / Ausgabe 2/2023
Print ISSN: 0937-9819
Elektronische ISSN: 1434-5196 - DOI
- https://doi.org/10.1007/s00194-022-00587-9
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
